Ranbaxy’s Troubled Decade
Executive Summary
Almost 10 years ago, the man who would go on to file the “whistleblower” complaint leading to Ranbaxy’s $500 million civil and criminal settlement with the U.S. government went to work for the Indian generic drug maker.